29 related articles for article (PubMed ID: 9615793)
1. MiR-376a-3p increases cell apoptosis in acute myeloid leukemia by targeting MT1X.
Xin X; Xu Z; Wei J; Zhang Y
Cancer Biol Ther; 2022 Dec; 23(1):234-242. PubMed ID: 35316152
[TBL] [Abstract][Full Text] [Related]
2. The roles of metallothioneins in carcinogenesis.
Si M; Lang J
J Hematol Oncol; 2018 Aug; 11(1):107. PubMed ID: 30139373
[TBL] [Abstract][Full Text] [Related]
3. A PU.1 suppressive target gene, metallothionein 1G, inhibits retinoic acid-induced NB4 cell differentiation.
Hirako N; Nakano H; Takahashi S
PLoS One; 2014; 9(7):e103282. PubMed ID: 25072246
[TBL] [Abstract][Full Text] [Related]
4. Molecular functions of metallothionein and its role in hematological malignancies.
Takahashi S
J Hematol Oncol; 2012 Jul; 5():41. PubMed ID: 22839501
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein-1 isoforms and vimentin are direct PU.1 downstream target genes in leukemia cells.
Imoto A; Okada M; Okazaki T; Kitasato H; Harigae H; Takahashi S
J Biol Chem; 2010 Apr; 285(14):10300-9. PubMed ID: 20139074
[TBL] [Abstract][Full Text] [Related]
6. [Multidrug resistance in the treatment of cancer].
Kuitunen T; Pyrhönen S
Duodecim; 1991; 107(22):1846-51. PubMed ID: 1365962
[No Abstract] [Full Text] [Related]
7. Glutathione system, topoisomerase II level and multidrug resistance phenotype in acute myelogenous leukemia before treatment and at relapse.
Massaad-Massade L; Ribrag V; Marie JP; Faussat AM; Bayle C; Dreyfus F; Gouyette A
Anticancer Res; 1997; 17(6D):4647-51. PubMed ID: 9494583
[TBL] [Abstract][Full Text] [Related]
8. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
9. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336
[TBL] [Abstract][Full Text] [Related]
10. Thymidylate synthase in childhood acute non-lymphoblastic leukemia.
Volm M; Zintl F; Sauerbrey A
Anticancer Res; 1994; 14(3B):1271-5. PubMed ID: 8067695
[TBL] [Abstract][Full Text] [Related]
11. [Expression and clinical significance of resistance proteins in initial acute lymphatic leukemia (ALL) in childhood].
Sauerbrey A; Volm M; Zintl F
Klin Padiatr; 1995; 207(4):230-4. PubMed ID: 7564159
[TBL] [Abstract][Full Text] [Related]
12. Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL).
Sauerbrey A; Zintl F; Hermann J; Volm M
Anticancer Res; 1998; 18(2B):1231-6. PubMed ID: 9615793
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance of acute leukemia and a strategy to overcome it.
Motoji T; Motomura S; Wang YH
Int J Hematol; 2000 Dec; 72(4):418-24. PubMed ID: 11197207
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]